CHLA researchers uncover mechanisms driving adult membranous nephropathy, which could potentially lead to novel treatments for pediatric chronic kidney disease.
Dr. Bhattacharjee is investigating potential therapies for the most severe form of fatty liver disease: metabolic dysfunction-associated steatohepatitis.